SeaChange, Envivio Team For Apple Ads
The SeaChange Infusion advanced advertising platform now will be included in Envivio 4Caster C4 Gen III encoders, “providing further options for multi-screen operators to monetize video delivered to Apple devices,” the companies say.
The two have been demonstrating the capabilities this week at CES, featuring demographically targeted ad insertion into live program streams on the Apple iPad. Infusion enables video operators to manage centralized ad operations and scale to 150,000 insertable channels and millions of ad assets as they migrate to consolidated regional and national advertising systems that are managed from increasingly Web-centric and virtualized datacenters.
Leveraging SCTE 130 and IAB VAST specifications, Infusion allows operators to determine which external ad servicing systems are sourced for dynamic placement decisions while creating opportunities for cross-platform campaigns and leveraging Internet campaign management pricing for TV content.
According to Envivio, operators deploying its encoding solutions in the video headend or the IT data center can deliver high-quality broadcast TV, HTTP adaptive streaming and 3GPP mobile video services. The software-based architecture at the heart of Envivio’s 4Caster multi-screen platform supports such functions as encoding, transcoding, packaging, encryption, publishing and ad insertion. Envivio products support SCTE 130 and SCTE 35 ad triggers to facilitate dynamic ad insertion to iOS and Android devices, PCs with Adobe Flash or Silverlight, connected TVs and traditional MPEG-2 and AVC set-top boxes.
In separate but related iPad news, video-delivery provider Azuki Systems says Showtime Networks has selected the Azuki Media Platform to power the network’s “Showtime Anytime” authentication service on the iPad. Showtime subscribers now will have instant access on their iPads to full-length Showtime series, movies, sports and comedy specials for free as part of their existing subscription through participating distributors. ?